{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:54:45Z","timestamp":1792212885354,"version":"4.4.0"},"reference-count":75,"publisher":"FapUNIFESP (SciELO)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Soc. Bras. Med. Trop."],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1590\/0037-8682-0138-2015","type":"journal-article","created":{"date-parts":[[2015,6,20]],"date-time":"2015-06-20T18:36:57Z","timestamp":1434825417000},"page":"235-242","source":"Crossref","is-referenced-by-count":78,"title":["New delivery systems for amphotericin B applied to the improvement of leishmaniasis treatment"],"prefix":"10.1590","volume":"48","author":[{"given":"Miguel Angel","family":"Ch\u00e1vez-Fumagalli","sequence":"first","affiliation":[{"name":"Universidade Federal de Minas Gerais,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana Gomes","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel Oliveira","family":"Castilho","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais,  Brazil; Universidade Federal de Minas Gerais,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone Od\u00edlia Antunes","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valbert Nascimento","family":"Cardoso","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cec\u00edlia Steinberg Perilo","family":"Coelho","sequence":"additional","affiliation":[{"name":"Bioprospection Ltda,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora Vasconcelos Costa","family":"Mendon\u00e7a","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Soto","sequence":"additional","affiliation":[{"name":"Universidad Aut\u00f3noma de Madrid,  Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Alberto Pereira","family":"Tavares","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Augusto Gomes","family":"Faraco","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais,  Brazil; Universidade Federal de Minas Gerais,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Antonio Ferraz","family":"Coelho","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais,  Brazil; Universidade Federal de Minas Gerais,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: Current situation and new perspectives","volume":"27","author":"Desjeux P","year":"2004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"ref2","first-page":"22","year":"2010"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar J","year":"2012","journal-title":"PLoS One"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1473-3099(02)00347-X","article-title":"Personal view visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda Personal view","volume":"2","author":"Guerin PJ","year":"2002","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"Chappuis F","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003527","article-title":"Health economic evaluations of visceral leishmaniasis treatments: a systematic review","volume":"9","author":"Marinho DS","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","article-title":"The relationship between leishmaniasis and AIDS: The second 10 years","volume":"21","author":"Alvar J","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.tmaid.2013.09.001","article-title":"Emergence of co-infection of visceral leishmaniasis in HIV-positive patients in northeast Iran: A preliminary study","volume":"12","author":"Shafiei R","year":"2014","journal-title":"Travel Med Infect Dis"},{"key":"ref9","series-title":"Topley and Wilson's Microbiology and Microbial Infections: parasitology","first-page":"313","volume-title":"New World leishmaniasis","author":"Lainson R","year":"2005","edition":"10th ed"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.ijpara.2005.07.001","article-title":"The current status of zoonotic leishmaniases and approaches to disease control","volume":"35","author":"Gramiccia M","year":"2005","journal-title":"Int J Parasitol"},{"key":"ref11","first-page":"378","article-title":"Liposomal amphotericin B versus pentavalent antimony salts for visceral Leishmania in children","volume":"55","author":"Apa H","year":"2013","journal-title":"Turk J Pediatr"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.actatropica.2011.05.012","article-title":"Importance of worldwide asymptomatic carriers of Leishmania infantum (L. chagasi) in human","volume":"119","author":"Michel G","year":"2011","journal-title":"Acta Trop"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1586\/14737159.3.5.657","article-title":"Molecular diagnosis of leishmaniasis","volume":"3","author":"Tavares CAP","year":"2003","journal-title":"Expert Rev Mol Diagn"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00436-011-2680-1","article-title":"Diagnosis of visceral leishmaniasis: Developments over the last decade","volume":"110","author":"Srividya G","year":"2012","journal-title":"Parasitol Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.exppara.2014.10.004","article-title":"Evaluation of indirect immunofluorescence antibody test and enzyme-linked immunosorbent assay for the diagnosis of infection by Leishmania infantum in clinically normal and sick cats","volume":"147","author":"Chatzis MK","year":"2014","journal-title":"Exp Parasitol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.3390\/ijerph7124267","article-title":"Antimony toxicity","volume":"7","author":"Sundar S","year":"2010","journal-title":"Int J Environ Res Public Health"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1086\/341406","article-title":"A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel","volume":"35","author":"Wortmann G","year":"2002","journal-title":"Clin Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4269\/ajtmh.2001.65.456","article-title":"Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate","volume":"65","author":"Romero GAS","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","article-title":"Drug resistance in Indian visceral leishmaniasis","volume":"6","author":"Sundar S","year":"2001","journal-title":"Trop Med Int Heal"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","article-title":"Leishmaniasis: current chemotherapy and recent advances in the search for novel drugs","volume":"19","author":"Croft SL","year":"2003","journal-title":"Trends Parasitol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1590\/S0037-86821985000300011","article-title":"Pentavalent antimonials: old drugs for new diseases","volume":"18","author":"Marsden PD","year":"1985","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-3024.1995.tb00962.x","article-title":"Cytotoxicity in human mucosal and cutaneous leishmaniasis","volume":"17","author":"Barral-Netto M","year":"1995","journal-title":"Parasite Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1086\/380638","article-title":"Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India","volume":"38","author":"Bhattacharya SK","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2147\/nano.2006.1.4.417","article-title":"Optimizing efficacy of amphotericin B through nanomodification","volume":"1","author":"Vyas SP","year":"2006","journal-title":"Int J Nanomedicine"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrd1086","article-title":"Hit and lead generation: beyond high-throughput screening","volume":"2","author":"Bleicher KH","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","article-title":"Principles of early drug discovery","volume":"162","author":"Hughes JP","year":"2011","journal-title":"Br J Pharmacol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/1874104501105010031","article-title":"Structures, targets and recent approaches in anti-leishmanial drug discovery and development","volume":"5","author":"Seifert K","year":"2011","journal-title":"Open Med Chem J"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/jac\/dkt318","article-title":"In vitro interaction between paromomycin sulphate and four drugs with leishmanicidal activity against three New World Leishmania species","volume":"69","author":"Morais-Teixeira E","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/jac\/dkn549","article-title":"Retrospective evaluation of amphotericin B deoxycholate toxicity in a single centre series of haematopoietic stem cell transplantation recipients","volume":"63","author":"Annaloro C","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"ref30","first-page":"877","article-title":"Novel targeting using nanoparticles: An approach to the development of an effective anti-leishmanial drug-delivery system","volume":"9","author":"Ribeiro TG","year":"2014","journal-title":"Int J Nanomedicine"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1086\/507530","article-title":"Liposomal amphotericin B for the treatment of visceral leishmaniasis","volume":"43","author":"Bern C","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.medmal.2009.05.001","article-title":"Le traitement de la leishmaniose visc\u00e9rale en Europe en 2009. Place de l'amphot\u00e9ricine B liposomale","volume":"39","author":"Rosenthal E","year":"2009","journal-title":"Med Mal Infect"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1468-3083.2010.03908.x","article-title":"Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica","volume":"25","author":"Solomon M","year":"2011","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1517\/14656566.2013.755515","article-title":"Leishmaniasis: an update of current pharmacotherapy","volume":"14","author":"Sundar S","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1023\/A:1026418814417","article-title":"Biodistribution of amphotericin B when delivered through cholesterol hemisuccinate vesicles in normal and A. fumigatus infected mice","volume":"17","author":"Saxena S","year":"2000","journal-title":"Pharm Res"},{"key":"ref36","first-page":"681","article-title":"Biodistribution of 4-{(14)C}cholesterol-AmBisome following a single intravenous administration to rats","volume":"29","author":"Townsend RW","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/10611860290007513","article-title":"Superior chemotherapeutic efficacy of amphotericin B in tuftsin-bearing liposomes against Leishmania donovani infection in hamsters","volume":"10","author":"Agrawal AK","year":"2002","journal-title":"J Drug Target"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1128\/AAC.46.3.828-833.2002","article-title":"Pharmacokinetics, Excretion, and mass balance of liposomal amphotericin B (Ambisome) and amphotericin B deoxycholate in humans","volume":"46","author":"Bekersky I","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/jac\/dkp140","article-title":"Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulation","volume":"64","author":"Gershkovich P","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/jbm.a.31504","article-title":"Amphotericin B-loaded poly(ethylene glycol)-poly(lactide) micelles: preparation, freeze-drying, and in vitro release","volume":"85","author":"Yang ZL","year":"2008","journal-title":"J Biomed Mater Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jconrel.2010.06.018","article-title":"Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain","volume":"147","author":"Shao K","year":"2010","journal-title":"J Control Release"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.exppara.2013.07.008","article-title":"Leishmanicidal activity of amphotericin B encapsulated in PLGA-DMSA nanoparticles to treat cutaneous leishmaniasis in C57BL\/6 mice","volume":"135","author":"Carvalho RF","year":"2013","journal-title":"Exp Parasitol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ijpharm.2013.05.044","article-title":"Development of oil-in-water microemulsions for the oral delivery of amphotericin B","volume":"454","author":"Silva AE","year":"2013","journal-title":"Int J Pharm"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/02652048809056475","article-title":"Possibilities of using nanoparticles as carriers for drugs and vaccines","volume":"5","author":"Kreuter J","year":"1988","journal-title":"J Microencapsul"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3109\/03639049809108571","article-title":"Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers","volume":"24","author":"Quintanar-Guerrero D","year":"1998","journal-title":"Drug Dev Ind Pharm"},{"key":"ref46","article-title":"Study the effects of PLGA-PEG encapsulated amphotericin B nanoparticle drug delivery system against Leishmania donovani","author":"Kumar R","year":"2014","journal-title":"Drug Deliv"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1021\/mp400603t","article-title":"Covalent functionalized self-assembled lipo-polymerosome bearing amphotericin B for better management of leishmaniasis and its toxicity evaluation","volume":"11","author":"Gupta PK","year":"2014","journal-title":"Mol Pharm"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0168-3659(01)00294-2","article-title":"Chitosan nanoparticles as delivery system for doxorubicin","volume":"73","author":"Janes KA","year":"2001","journal-title":"J Control Rel"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nmat3222","article-title":"Synthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes","volume":"11","author":"John AL","year":"2012","journal-title":"Nat Mater"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0939-6411(99)00040-5","article-title":"Chitosan and chondroitin microspheres for oral-administration controlled release of metoclopramide","volume":"48","author":"Ganza-Gonz\u00e1lez A","year":"1999","journal-title":"Eur J Pharm Biopharm"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.colsurfb.2008.02.022","article-title":"Preparation and properties of chitosan chondroitin sulfate complex microcapsules","volume":"65","author":"Sui W","year":"2008","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.carbpol.2009.11.007","article-title":"Preparation of chitosan\/chondroitin sulfate complex microcapsules and application in controlled release of 5-fluorouracil","volume":"80","author":"Huang L","year":"2010","journal-title":"Carbohydr Polym"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2009.07.019","article-title":"Chitosan-based hydrogels for controlled, localized drug delivery","volume":"62","author":"Bhattarai N","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1021\/la048711o","article-title":"Influence of pH, ionic strength, and temperature on self-association and interactions of sodium dodecyl sulfate in the absence and presence of chitosan","volume":"21","author":"Thongngam M","year":"2005","journal-title":"Langmuir"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.joca.2008.06.008","article-title":"Anti-inflammatory activity of chondroitin sulfate","volume":"16","author":"Iovu M","year":"2008","journal-title":"Osteoarthr Cartil"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1016\/S0142-9612(02)00100-X","article-title":"Glycosaminoglycan hydrogel films as bio-interactive dressings for wound healing","volume":"23","author":"Kirker KR","year":"2002","journal-title":"Biomaterials"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1016\/S0142-9612(02)00100-X","article-title":"Glycosaminoglycan hydrogel films as bio-interactive dressings for wound healing","volume":"23","author":"Kirker KR","year":"2002","journal-title":"Biomaterials"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/app.10662","article-title":"Insolubilization of sodium chondroitin sulfate by forming a semi-interpenetrating polymer network with acrylic acid: A potential carrier for colon-specific drug delivery","volume":"85","author":"Wang LF","year":"2002","journal-title":"J Appl Polym Sci"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0142-9612(95)98820-5","article-title":"Cross-linked chondroitin sulphate: Characterization for drug delivery purposes","volume":"16","author":"Sintov A","year":"1995","journal-title":"Biomaterials"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nrd2144","article-title":"Innovative lead discovery strategies for tropical diseases","volume":"5","author":"Nwaka S","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"ref61","first-page":"5341","article-title":"An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasis","volume":"9","author":"Ribeiro TG","year":"2014","journal-title":"Int J Nan"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijpharm.2008.06.004","article-title":"Particle size-dependent triggering of accelerated blood clearance phenomenon","volume":"362","author":"Koide H","year":"2008","journal-title":"Int J Pharm"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1021\/bc700425x","article-title":"Amphiphilic copolymer for delivery of xenobiotics: in vivo studies in a freshwater invertebrate, a mesostominae flatworm","volume":"19","author":"Jong L","year":"2008","journal-title":"Bioconjug Chem"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s00436-011-2628-5","article-title":"Evaluation of parasitological and immunological parameters of Leishmania chagasi infection in BALB\/c mice using different doses and routes of inoculation of parasites","volume":"110","author":"Oliveira DM","year":"2012","journal-title":"Parasitol Res"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/bj2170199","article-title":"Comparative study on glycosaminoglycans synthesized in peripheral and peritoneal polymorphonuclear leucocytes from guinea pigs","volume":"217","author":"Ohhashi Y","year":"1984","journal-title":"Biochem J"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1073\/pnas.85.7.2284","article-title":"Identification of chondroitin sulfate E proteoglycans and heparin proteoglycans in the secretory granules of human lung mast cells","volume":"85","author":"Stevens RL","year":"1988","journal-title":"Proc Natl Acad Sci"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1042\/BJ20031851","article-title":"Chondroitin sulphate structure affects its immunological activities on murine splenocytes sensitized with ovalbumin","volume":"382","author":"Akiyama H","year":"2004","journal-title":"Biochem J"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/labinvest.3700327","article-title":"Expression of mannose receptor and ligands for its cysteine-rich domain in venous sinuses of human spleen","volume":"85","author":"Martinez-Pomares L","year":"2005","journal-title":"Lab Invest"},{"key":"ref69","first-page":"481","article-title":"Amphotericin B Nephotoxicity","volume":"13","author":"Bagnis CI","year":"2002","journal-title":"Saudi J Kidney Dis Transplant"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1128\/AAC.01137-08","article-title":"Amphotericin B-induced renal tubular cell injury is mediated by Na+ influx through ion-permeable pores and subsequent activation of mitogen-activated protein kinases and elevation of intracellular Ca2+ concentration","volume":"53","author":"Takahisatyano Y","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"37561","DOI":"10.1074\/jbc.M306137200","article-title":"The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism","volume":"278","author":"Sau K","year":"2003","journal-title":"J Biol Chem"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/jac\/dkh542","article-title":"Liposomal amphotericin B activates antifungal resistance with reduced toxicity by diverting Toll-like receptor signalling from TLR-2 to TLR-4","volume":"55","author":"Bellocchio S","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/jac\/dkt055","article-title":"An elevated pro-inflamatory cytokine response is linked to development of amphotericin B-induced nephrotoxicity","volume":"68","author":"Chai LY","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1128\/AAC.00001-09","article-title":"Reduction of amphotericin B-induced renal tubular apoptosis by N-acetylcysteine","volume":"53","author":"Odabasi Z","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s13181-010-0120-8","article-title":"An Evaluation of hepatotoxicity and nephrotoxicity of liposomal amphotericin B (L-AMB)","volume":"7","author":"Patel GP","year":"2011","journal-title":"J Med Toxicol"}],"container-title":["Revista da Sociedade Brasileira de Medicina Tropical"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rsbmt\/v48n3\/0037-8682-rsbmt-48-03-00235.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T21:07:03Z","timestamp":1495487223000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0037-86822015000300235&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0037-86822015000300235"],"URL":"https:\/\/doi.org\/10.1590\/0037-8682-0138-2015","relation":{},"ISSN":["0037-8682"],"issn-type":[{"value":"0037-8682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}